CompanyGraph
What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $1.38B, above the global median of $1.18B
- FinancialsAltman Z-Score 3.83: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
3.25%Below 5Y avg (3.81%)
Annual Rate
CNY 0.52Paid semi-annual
Payout Ratio
227.4%High
Payback Period
32.0 yr
Last Ex-Dividend
Jun 22, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.22BCNY1.38B · vs all stocks (USD)
Trailing P/E
69.74xvs Medical Instruments & Supplies peers
Revenue (TTM)
1.61BCNY239.83M · vs all stocks (USD)
Profit Margin
8.35%vs Medical Instruments & Supplies peers
Beta
0.4920xvs all stocks
52-Week Change
-20.99%vs all stocks
Forward Annual Dividend Yield
3.25%vs all stocks
Market Capitalization
9.22BCNY1.38B · vs all stocks (USD)
Enterprise Value
6.90BCNY1.03B · vs all stocks (USD)
Trailing P/E
69.74xvs Medical Instruments & Supplies peers
Forward P/E
20.30xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
5.74xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.31xvs Medical Instruments & Supplies peers
Enterprise to Revenue
4.29xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
26.38xvs Medical Instruments & Supplies peers
Gross Margin
69.13%vs Medical Instruments & Supplies peers
Profit Margin
8.35%vs Medical Instruments & Supplies peers
Operating Margin
-3.12%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
0.24%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
1.28%vs Medical Instruments & Supplies peers
Revenue (TTM)
1.61BCNY239.83M · vs all stocks (USD)
Revenue per Share (TTM)
2.76CNYUpdated Sep 20, 2026Quarterly Revenue Growth
1.00%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
1.17BCNY174.22M · vs all stocks (USD)
EBITDA (TTM)
426.81MCNY63.69M · vs all stocks (USD)
Net Income (TTM)
134.24MCNY20.03M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-32.00%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
311.15MCNY46.43M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-247.92MCNY-37.00M · vs all stocks (USD)
Forward Annual Dividend Rate
0.5220CNYUpdated Sep 20, 2026Forward Annual Dividend Yield
3.25%vs all stocks
Trailing Annual Dividend Rate
0.5230CNYUpdated Sep 20, 2026Trailing Annual Dividend Yield
3.25%vs all stocks
5-Year Average Dividend Yield
3.81%vs all stocks
Payout Ratio
227.39%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
73.98MCNYFY2025 · Dec 31, 2025Revenue
1.64BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
397.48MCNYFY2025 · Dec 31, 2025Gross Profit
1.24BCNYFY2025 · Dec 31, 2025Operating Income
210.49MCNY31.41M · vs all stocks (USD)
Pre-tax Income
175.08MCNYFY2025 · Dec 31, 2025Income Tax Expense
21.16MCNYFY2025 · Dec 31, 2025Net Income
153.92MCNYFY2025 · Dec 31, 2025EBIT
199.21MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
426.81MCNYFY2025 · Dec 31, 2025Research & Development
229.11MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
377.97MCNYFY2025 · Dec 31, 2025Other Operating Expenses
19.70MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
86.82MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
24.13MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3400CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3400CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
585.11MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
585.11MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
153.92MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
45.01MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
137.88MCNYFY2025 · Dec 31, 2025Free Cash Flow
-229.44MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
3.75BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
153.92MCNYFY2025 · Dec 31, 2025Other Non-cash Items
43.56MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-39.97MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-19.64MCNYFY2025 · Dec 31, 2025Capital Expenditures
-367.32MCNYFY2025 · Dec 31, 2025Net Acquisitions
-715.47MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.05BCNYFY2025 · Dec 31, 2025Sale of Investments
847.50MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.29BCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.11BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-403.13MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-333.68MCNYFY2025 · Dec 31, 2025Other Financing Charges
4.58MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
374.38MCNYFY2025 · Dec 31, 2025Shares Outstanding
579.39MSharesUpdated Sep 20, 2026Float Shares
291.49MSharesUpdated Sep 20, 2026% Held by Insiders
48.04%vs all stocks
% Held by Institutions
6.44%vs all stocks
Total Cash (MRQ)
3.82BCNY570.11M · vs all stocks (USD)
Total Cash per Share (MRQ)
6.72CNYUpdated Sep 20, 2026Total Debt (MRQ)
1.53BCNY227.57M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2156xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
4.67xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
12.26CNYUpdated Sep 20, 2026Total Assets
9.53BCNY1.42B · vs all stocks (USD)
Total Current Assets
5.27BCNYFY2025 · Dec 31, 2025Total Liabilities
2.34BCNYFY2025 · Dec 31, 2025Total Non-current Assets
4.25BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.13BCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.21BCNYFY2025 · Dec 31, 2025Cash
3.84BCNYFY2025 · Dec 31, 2025Cash Equivalents
125.17MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
3.97BCNYFY2025 · Dec 31, 2025Other Short-term Investments
157.10MCNYFY2025 · Dec 31, 2025Accounts Receivable
621.44MCNYFY2025 · Dec 31, 2025Inventory
413.69MCNYFY2025 · Dec 31, 2025Accounts Payable
364.79MCNYFY2025 · Dec 31, 2025Short-term Debt
148.85MCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.31MCNYFY2025 · Dec 31, 2025Long-term Debt
978.47MCNYFY2025 · Dec 31, 2025Common Stock (Book)
579.39MCNYFY2025 · Dec 31, 2025Retained Earnings
4.79BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
7.19BCNY1.07B · vs all stocks (USD)
Treasury Stock
143.23MCNYFY2025 · Dec 31, 202552-Week Low
13.40CNYUpdated Sep 20, 202652-Week High
22.94CNYUpdated Sep 20, 202652-Week Change
-20.99%vs all stocks
Beta
0.4920xvs all stocks
50-Day MA
15.66CNYUpdated Sep 20, 2026200-Day MA
17.38CNYUpdated Sep 20, 2026Avg 10-Day Volume
3.78MSharesUpdated Sep 20, 2026Avg 30-Day Volume
7.48MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
0.2300CNYUpdated Sep 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 2.27Dividend per Share: 0.52Earnings per Share: 0.23
Financial Health
Altman Z-Score 3.83: safe zoneNotable
Altman Z-Score: 3.83
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.38B, above the global median of $1.18BNotable
Market cap (USD): 1,376,107,280.348Global Median: 1,180,223,658.953
Companies that share the same coordination system — how they create, deliver, or capture value.
Guangdong Cellwise Microelectronics Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Ningbo Changhong Polymer Scientific Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Sunvim Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Chongqing Chuanyi Automation Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
MillerKnoll, Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Rigol Technologies Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Dalian Baiao Chemicals Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sinofert Holdings Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Adient plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Sofarsolar Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationCash Elevated Relative to Current Liabilities and Total Assets
XGD Inc.
1 interpretationCash Elevated Relative to Current Liabilities and Total Assets
Lingda Group Co., Ltd.
1 interpretationCash Elevated Relative to Current Liabilities and Total Assets